Moore Capital Management’s Pfizer PFE Stock Holding History

Moore Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-500,000	Closed	-$12.4M	–	769
2025 Q4	$12.4M	Buy	+500,000	New	+$12.6M	0.18%	130
2025 Q1	–	Sell	-140,000	Closed	-$3.71M	–	592
2024 Q4	$3.71M	Buy	+140,000	New	+$3.8M	0.04%	274
2023 Q4	–	Sell	-200,000	Closed	-$6.63M	–	516
2023 Q3	$6.63M	Buy	+200,000	New	+$7.07M	0.12%	127
2016 Q2	–	Sell	-210,800	Closed	-$5.93M	–	314
2016 Q1	$5.93M	Buy	+210,800	New	+$6.02M	0.24%	119
2015 Q3	–	Sell	-843,200	Closed	-$26.8M	–	374
2015 Q2	$26.8M	Buy	+843,200	New	+$27.5M	0.58%	29
2015 Q1	–	Sell	-632,400	Closed	-$18.7M	–	455
2014 Q4	$18.7M	Hold	632,400	–	–	0.59%	39
2014 Q3	$17.7M	Sell	632,400 -527,000	-45%	-$14.8M	0.41%	58
2014 Q2	$32.6M	Buy	1,159,400 +527,000	+83%	+$15M	0.79%	25
2014 Q1	$19.3M	Buy	+632,400	New	+$18.9M	0.39%	54

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Moore Capital Management's PFE Position: Q2 2025 in Review

Moore Capital Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 250,000 shares — an estimated $6.33M sold.

Moore Capital Management first reported a position in PFE in Q3 2013 and held it in 10 quarters. The position peaked at $17.1M in Q4 2014. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Moore Capital Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Moore Capital Management sold 250,000 Pfizer shares in Q2 2025, an estimated $6.33M.
Moore Capital Management first reported a position in Pfizer in Q3 2013 and held it in 10 quarters.
Moore Capital Management's Pfizer position peaked at $17.1M in Q4 2014.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Moore Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.